MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clml.2026.04.020

Медицинская библиотека · Clinical lymphoma, myeloma & leukemia · 2026

Thrombocytosis Phenotype in Prefibrotic Primary Myelofibrosis: Risk Stratification and Prognostic Significance.

Lin Chun-Hao, Tsai Chun-Kuang, Hsu Te-Lin, Yeh Chiu-Mei, Gau Jyh-Pyng, Liu Chia-Jen

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Essential thrombocythemia, prefibrotic primary myelofibrosis (pre-PMF), and overt primary myelofibrosis are myeloproliferative neoplasms with overlapping clinical features but different prognoses. We investigated the prognostic impact of thrombocytosis in pre-PMF.

METHODS

This retrospective study analyzed patients diagnosed with myeloproliferative neoplasms at Taipei Veterans General Hospital from 2002 to 2023. Diagnoses were assigned by integrated clinicopathologic review using World Health Organization criteria. Overall survival was analyzed using Cox proportional hazards models. For complication endpoint, including leukemic transformation, thrombosis, and bleeding, competing-risk methods were used, with death treated as a competing event.

RESULTS

Among 350 patients with myeloproliferative neoplasms, the median age was 68 years, and 60.3% were male. Compared with pre-PMF patients without thrombocytosis, essential thrombocythemia did not have a significantly different risk of death (hazard ratio [HR] 0.77, 95% confidence interval [CI] 0.30-1.97; P = .586), whereas overt primary myelofibrosis had a significantly higher risk of death (HR 2.80, 95% CI 1.10-7.10; P = .030). In pre-PMF, thrombocytosis had a higher risk of death (HR 4.33, 95% CI 1.03-18.12; P = .045). Prognostic factors for worse survival in pre-PMF included constitutional symptoms (adjusted HR 10.81, 95% CI 2.63-44.36, P = .001), leukocytosis (adjusted HR 7.69, 95% CI 1.94-30.54, P = .004), and thrombocytosis (adjusted HR 7.80, 95% CI 1.49-40.82, P = .015).

CONCLUSIONS

Thrombocytosis was associated with inferior overall survival in pre-PMF. These findings support platelet count as a pragmatic risk stratifier in pre-PMF and highlight the clinical relevance of distinguishing pre-PMF from essential thrombocythemia and overt primary myelofibrosis.

Для цитирования: Lin Chun-Hao, Tsai Chun-Kuang, Hsu Te-Lin, Yeh Chiu-Mei, Gau Jyh-Pyng, Liu Chia-Jen. Thrombocytosis Phenotype in Prefibrotic Primary Myelofibrosis: Risk Stratification and Prognostic Significance.. Clinical lymphoma, myeloma & leukemia. 2026. DOI: 10.1016/j.clml.2026.04.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.